AEs / CBC / Creative Commons / BioMed Central Ltd. / German Pharmaceuticals / /
Country
Germany / / /
Event
FDA Phase / Product Issues / /
Facility
University Hospital Heidelberg / University Hospital Heidelberg Hartwig / University of Heidelberg / Institute of Medical Biometry / / /
IndustryTerm
cell product / treatment of this disease / frequent communications / donor search / larger randomized protocols / clinical study protocol / trial site / study protocol / treatment for pancreatic cancer / /
MedicalCondition
hematopoietic tumor / refractory disease / medical conditions/diseases / durable disease / hematological neoplasms / insulin-dependent diabetes mellitus / HIV / residual disease / Dementia / HBV / surgical tumor / distant metastasis / long-term disease / renal cancer / resected pancreatic adenocarcinoma prognostic factors / severe infections / otherwise mostly fatal disease / breast cancer / least stable disease / hematological diseases / adenocarcinoma / pancreatic adenocarcinoma / tumor / colon carcinoma / otherwise lethal disease / basis Schmitz-Winnenthal et al. BMC Cancer / cancer / neoplasm / advanced solid tumors / Symptomatic coronary artery disease / actively proliferative tumor / pancreatic cancers / bulky and uncontrolled tumor / pancreatic ductal adenocarcinoma / Also pancreatic cancer / fast progressing tumor / also pancreatic cancers / GVHD-mediated inflammation / hematopoietic malignancies / primary tumor / anti-tumor activity Schmitz-Winnenthal et al. BMC Cancer / allo-HSCT Schmitz-Winnenthal et al. BMC Cancer / high initial tumor / advanced disease / large pancreatic tumor / pancreatic cancer tumors / advanced pancreatic cancer / solid cancer / solid tumors / ductal adenocarcinoma remains / carcinoma / Schmitz-Winnenthal et al. BMC Cancer / above / effective GvT-mediated disease / study tumor / western world pancreatic cancer / relapsed and high-risk hematological malignancies / Chronic renal dysfunction / leukemias / GvT-mediated disease / Pancreatic cancer / least pancreatic cancer / Minimal PAncreatic Cancer / common cancer / minimal disease / minimal residual disease / large tumor / disease / solid tumor / progressive disease / routine tumor / pancreatic carcinoma / advanced Schmitz-Winnenthal et al. BMC Cancer / long term disease / pre-transplant tumor / different solid tumors response / Background Rationale Pancreatic cancer / infectious foci / objective tumor / hematopoietic and epithelial tumor / /
Department of General / University of Heidelberg / Informatics Heidelberg / Institute of Medical Biometry and Informatics Heidelberg / Data Monitoring and Safety Committee / Trial Pharmacovigilance Office / Department of General / Visceral and Transplantation Surgery / Medical Ethics Committee / Ministry of Health / National Institute of Health / Coordination Centre for Clinical Trials Heidelberg / Department of Hematology / Oncology and Rheumatology / Institute of Medical Biometry / Funding Heidelberg Surgery Foundation / Ethics Committee / /
Clinical characteristics and prognosis of osteosarcoma in young children: a retrospective series of 15 cases